Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas

OBJECTIVE: Leukocyte‐associated immunoglobulin‐like receptor‐1 (LAIR‐1), is an immunosuppressive receptor, widely expressed by immune cells, but the part of LAIR‐1 in glioma progression remains unclear. The purpose of this study was to explore the relationship between LAIR‐1 expression and the devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Zhansheng, Lin, Li, Tu, Zewei, Zhu, Xingen, Li, Jingying, Luo, Pengxiang, Huang, Kai, Wu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844621/
https://www.ncbi.nlm.nih.gov/pubmed/35702880
http://dx.doi.org/10.1002/cam4.4945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844621/
https://www.ncbi.nlm.nih.gov/pubmed/35702880
http://dx.doi.org/10.1002/cam4.4945

Ejemplares similares